3[1]Feldman EL,Stevens MJ,Green DA.Pathogenesis of diabetic neuropathy[J].Clin-Neurosci,1997,4(6):365-370.
4Ueshiba H,Shimizu Y,Hiroi N,et al.Decreased steroidogenic enzyme 17,20-lyase and increased 17-hydroxylase activities in type 2 diabetes mellitus.Eur J Endocrinol,2002,146:375-380.
5Suzuki M,Kanazawa A,Hasegawa M,et al.A close association between insulin resistance and dehydroepiandrosterone sulfate in subjects with essential hypertension.Endocr J,1999,46:521-528.
6Boudou P,Kerviler E,Eelich D,et al.Exercise training-induced triglyceride lowering negatively correlates with DHEA levels in men with type 2 diabetes.Int J Obes Relat Metab Disord,2001,25:1108-1112.
7Byrne JJ,Bradlow HL.DHEA-PC slows the progression of type 2 diabetes (non-insulin-dependent diabetes mellitus) in the ZDF/Gmi-fa/fa rat.Diabetes Technol Ther,2001,3:211-219.
8Kameda W,Daimon M,Oizumi T,et al.Association of decrease in serum dehydroepiandrosterone sulfate levels with the progression to type 2 diabetes in men of a Japanese population:the Funagata Study.Metabolism,2005,54:669-676.
9Yorek MA,Coppey LJ,Gellett JS,et al.Effect of treatment of diabetic rats with dehydroepiandrosterone on vascular and neural function.Am J Physiol Endocrinol Metab,2002,283:E1067-E1075.
10Aragno M,Parola S,Brignardello E,et al.Oxidative stress and eicosanoids in the kidneys of hyperglycemic rats treated with dehydroepiandrosterone.Free Radic Biol Med,2001,31:935-942.
